bmi for tirzepatide Is appropriate weight loss in a non‑diabetic adult with obesity (BMI ≥ 30 kg/m² or ≥ 27 kg/m² with a weight‑related comorbidity)? Tirzepatide for Medical Weight Loss

Additional factors such as increased release of adiponectin from adipose tissue, amelioration of insulin resistance in liver and peripheral tissues, and improved circulatory lipid profile all contribute to the reduced risk of ASCVD (267)

Animal studies serve an important role in identifying potential concerns that warrant human investigation

So even if your appetite is reduced, you can still consume hundreds of extra calories without feeling satisfied

Additionally, if the dose remains subtherapeutic for an individual's physiology, the expected appetite reduction may not materialise

Gill A, Hoogwerf BJ, Burger J, Bruce S, Macconell L, Yan P, Braun D, Giaconia J, Malone J